Keyphrases
Matrix Mineralization
100%
Proton Pump Inhibitors
100%
PHOSPHO1
100%
Inhibitory Effect
28%
Concentration-dependent
14%
IC50
14%
Ranitidine
14%
Cimetidine
14%
Fracture Risk
14%
Bone Loss
14%
Gastric Acid
14%
Skeletal Effects
14%
Primary Osteoblasts
14%
Phosphatase
14%
Pantoprazole
14%
Secondary Hyperparathyroidism
14%
Pharmacoepidemiology
14%
Nizatidine
14%
Intestinal Calcium Absorption
14%
Histamine-2 Receptor Antagonists (H2RA)
14%
Esomeprazole
14%
Bone Matrix
14%
Tissue-nonspecific Alkaline Phosphatase
14%
Famotidine
14%
Fragility Fracture
14%
Medicine and Dentistry
In Vitro
100%
Mineralization
100%
Proton-Pump Inhibitor
100%
Osteolysis
14%
Osteoblast
14%
IC50
14%
Phosphatase
14%
Secondary Hyperparathyroidism
14%
Ranitidine
14%
Pantoprazole
14%
Bone Matrix
14%
Calcium Absorption
14%
Nizatidine
14%
H2 Antagonist
14%
Famotidine
14%
Cimetidine
14%
Fragility Fracture
14%
Esomeprazole
14%
Veterinary Science and Veterinary Medicine
Osteolysis
100%
Gastric Acid
100%
Secondary Hyperparathyroidism
100%
Osteoblast
100%
Cimetidine
100%
Biochemistry, Genetics and Molecular Biology
Mineralization
100%
Proton Pump
100%
Osteoblast
14%
Osteolysis
14%
H2 Antagonist
14%
Ranitidine
14%
IC50
14%
Nizatidine
14%
Calcium Absorption
14%
Esomeprazole
14%
Pantoprazole
14%
Famotidine
14%
Phosphatase
14%
Cimetidine
14%
Immunology and Microbiology
Mineralization
100%
Osteoblast
33%
IC50
33%
Osteolysis
33%
Calcium Absorption
33%
Bone Matrix
33%
Histamine
33%
Pharmacology, Toxicology and Pharmaceutical Science
Proton Pump Inhibitor
100%
IC50
14%
Histamine H2 Receptor Antagonist
14%
Ranitidine
14%
Nizatidine
14%
Esomeprazole
14%
Cimetidine
14%
Fragility Fracture
14%
Pantoprazole
14%
Secondary Hyperparathyroidism
14%
Famotidine
14%
Phosphatase
14%